"A World of Opportunities"
22 - 24 July 2019
Paradise Island Resort & Spa, Maldives
22 - 24 July 2019
Paradise Island Resort & Spa, Maldives
People in their mid-30s need to watch their blood pressure to protect brain health in later life, says a study..
People in their mid-30s need to watch their blood pressure to protect brain health in later life, says a study. It found the "window of opportunity" to safeguard brain health runs from then until the early-50s. Following 500 people born in 1946, it linked higher blood pressure in early mid-life to later blood vessel damage and brain shrinkage. Experts said high blood pressure in the "critical period" of the 30s and 40s could "accelerate damage" to the brain. Following 500 people born in 1946, it linked higher blood pressure in early mid-life to later blood vessel damage and brain shrinkage. Experts said high blood pressure in the "critical period" of the 30s and 40s could "accelerate damage" to the brain. This is not the first time raised blood pressure in middle age has been linked to increased dementia risk, but the scientists wanted to understand more about when and how it might happen. Throughout this study, published in Lancet Neurology, participants had their blood pressure measured and underwent brain scans. • Lifestyle changes that could lower your dementia risk • Dementia is 'greatest health challenge' • Throughout this study, published in Lancet Neurology, participants had their blood pressure measured and underwent brain scans. Lifestyle changes that could lower your dementia risk Dementia is 'greatest health challenge' Minority take up 'life-saving' free health check Increases in blood pressure between the ages of 36 and 43 were associated with brain shrinkage.
• The Food and Drug Administration is proposing a rule that would inform women about how breast density may influence mammogram results.
• Dense breast tissue makes it harder for doctors to see cancer, meaning the tests can be less accurate. The agency is also proposing tightening its regulation of mammogram testing.
(Reuters) - A European Medicines Agency panel on Friday recommended a conditional marketing approval for a gene therapy from Bluebird Bio Inc as a genetic blood disorder treatment, setting the stage for the U.S. biotech to win its first regulatory nod. Final approval depends on the European Commission, which generally follows recommendations from the Committee on Human Medicinal Products (CHMP). The decision is expected in the second quarter, Bluebird said in a statement
The FDA is stepping up its formal review of non-dairy alternatives such as almond milk. Commissioner Scott Gottlieb attracted national attention when he jokingly pointed out at a Politico summit in July that "an almond doesn't lactate." The agency is soliciting feedback on how the public uses and perceives plant-based dairy alternatives, such as almond milk.
• A New Jersey jury on Wednesday cleared Johnson & Johnson of liability in a lawsuit by a man who alleged asbestos in the company's talc-based products, including baby powder, caused his mesothelioma.
• J&J, which faces some 13,000 talc-related lawsuits nationwide, denies that its talc causes cancer, saying numerous studies and tests by regulators worldwide have shown its talc to be safe and asbestos-free. J&J in a statement said the jury's decision underscored decades of clinical evidence and scientific studies by medical experts around the world supporting the safety of Johnsons Baby Powder
• "What I've always found [is] when there's a certain amount of uncertainty, there's a challenging environment, that's the time to act," Centene CEO Michael Neidorff says about its acquisition of WellCare.
• "There was a time this stock was a lot higher ... The time was right and some things don't come back around," he says.
• We have a lot of time and patience for our long-term investors and we have a lot of them. And I'm willing to bet a year from now we sit down and talk you're going to say to me: 'You did it at the right time," he says.
The plans cover less and follow fewer rules than most insurance that you can buy now. They are also less costly and will be marketed extensively.
At least 15 states have identified more than 120 cases of lung disease or injury that could be linked to vaping, a CNN survey of state health departments has found. The US Centers for Disease Control and Prevention said on Saturday it's investigating severe pulmonary disease among people who use e-cigarettes in some states.
FDA investigating 127 reports of seizures, neurological symptoms related to vaping
States with the most cases include Wisconsin, with 15 confirmed cases and 15 more under investigation, according to CNN's survey. Illinois has 10 confirmed cases, while 12 more are under investigation. California is looking into 19 such cases. The New York State Department of Health said Friday it was "actively investigating" 11 cases. Indiana and New Jersey both reported nine cases, of which Indiana has confirmed six. Health officials in Connecticut, Florida, Iowa, Michigan, Minnesota, North Carolina, Pennsylvania, Texas and Utah also said they were aware of confirmed or potential cases. A total of 42 states and Washington, DC, provided CNN with a response. "These latest reports of pulmonary disease in people using vaping products in New York and other states are proof that more study is needed on the long-term health effects of these products," Dr. Howard Zucker, health commissioner for New York State, said in a statement Friday. The CDC said Saturday it had counted 94 possible cases of severe lung illness associated with vaping in 14 states from June 28 to August 15. It is concerned about how time spent online impacts on mood, sleep, diet and behaviour.
The government is expected to announce plans to regulate social media companies soon.